Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofibrate versus ursodeoxycholic acid with phototherapy for neonatal unconjugated jaundice
IRCT20260718070242N1Phase 3Completed
- Sponsor
- Ilam University of Medical Sciences
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of clofibride and ursodeoxycholic acid in hyperbilirubinemia (2 arms), sponsored by Ilam University of Medical Sciences. Primary endpoint: Duration of phototherapy. Started Aug 2026; status: completed.
02
Drugs
clofibrideursodeoxycholic acid
03
Conditions
hyperbilirubinemia
Beyond the preview
Go deeper on IRCT20260718070242N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260718070242N1.